Associated Papers
TNF Receptor-Associated Periodic Syndrome: An Analysis of a Slovakian Cohort of TRAPS Patients.
Slenker B et al.
Archives of Rheumatology, 2025
Characterization of Genetic Landscape and Novel Inflammatory Biomarkers in Patients With Adult-Onset Still's Disease.
Topping J et al.
Arthritis & Rheumatology (hoboken, N.j.), 2025
Are transient protein-protein interactions more dispensable?
Ghadie MA et al.
Plos Computational Biology, 2022
35404956 (PubMed )
Supplement: pcbi.1010013.s002.xlsx › _D__Lit-SI_disMut_edgotypes
Tumour necrosis factor receptor-1 associated periodic syndrome (TRAPS)-related AA amyloidosis: a national case series and systematic review.
Delaleu J et al.
Rheumatology (oxford, England), 2021
TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS.
Rittore C et al.
Scientific Reports, 2021
Revisiting TNF Receptor-Associated Periodic Syndrome (TRAPS): Current Perspectives.
Cudrici C et al.
International Journal of Molecular Sciences, 2020
Functional analysis of a novel G87V TNFRSF1A mutation in patients with TNF receptor-associated periodic syndrome.
Tsuji S et al.
Clinical and Experimental Immunology, 2019
Treating TNF Receptor Associated Periodic Fever Syndrome in End-Stage Renal Failure.
Coutinho J et al.
Case Reports in Nephrology, 2019
Evidence for genetic overlap between adult onset Still's disease and hereditary periodic fever syndromes.
Sighart R et al.
Rheumatology International, 2018
A novel TNFRSF1A splice mutation associated with increased nuclear factor kappaB (NF-kappaB) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS).
Churchman SM et al.
Annals of the Rheumatic Diseases, 2008
Select a paper to view details